Family Medicine · Beaver Falls, PA
NPI
1841240660
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
2580 Constitution Blvd
Beaver Falls, PA, 15010
Phone (724) 773-6844
Groups this clinician bills Medicare through
Medicare paid, 2024
$79K
2,695 services
Medicare patients, 2024
222
Average age 72
Drug cost, 2024
$1.6M
13,225 prescriptions
Company payments, 2025
$86.23
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert F Palguta Jr. was code J0897 (injection, denosumab, 1 mg), 1,200 times for 14 patients. In total Robert F Palguta Jr. billed 2,695 services in 33 codes, and Medicare paid $79K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-09-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,200 | 14 | $20.12 | $24K |
| 99214 Office E&M - Established | Office | 479 | 201 | $76.47 | $37K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 81 | 75 | $11.17 | $905 |
| G0008 Administration of influenza virus vaccine | Office | 71 | 71 | $30.75 | $2,183 |
| 90662 Vaccine Product | Office | 66 | 66 | $81.82 | $5,400 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 48 | 12 | $0.72 | $34.37 |
| 99213 Office E&M - Established | Office | 41 | 37 | $56.49 | $2,316 |
| 96372 Injection Administration | Office | 25 | 20 | $10.26 | $257 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 21 | 16 | $154.80 | $3,251 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 15 | 15 | $38.13 | $572 |
| 90656 Vaccine Product | Office | 11 | 11 | $21.90 | $241 |
By year: 2022 $81K for 2,251 services; 2023 $85K for 2,507 services; 2024 $79K for 2,695 services.
Medicare prescription drug claims, 2024
In 2024, the drug Robert F Palguta Jr. prescribed most often to Medicare patients was Rosuvastatin Calcium, with 988 prescriptions and refills. In total Robert F Palguta Jr. wrote 13,225 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 988 | 2,721 | 289 | $16K |
| Atorvastatin Calcium Generic | 534 | 1,510 | 150 | $5,103 |
| Levothyroxine Sodium Generic | 435 | 1,165 | 113 | $4,956 |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 433 | 1,120 | 123 | $17K |
| Omeprazole Generic | 358 | 936 | 102 | $4,165 |
| Amlodipine Besylate Generic | 323 | 873 | 90 | $1,813 |
| Gabapentin Generic | 321 | 555 | 82 | $6,668 |
| Duloxetine Hcl Generic | 308 | 707 | 81 | $6,522 |
| Mounjaro Tirzepatide | 241 | 275 | 46 | $282K |
| Metformin Hcl Generic | 240 | 657 | 69 | $1,987 |
| Lisinopril Generic | 231 | 647 | 68 | $1,462 |
| Lisinopril-Hydrochlorothiazide Lisinopril/Hydrochlorothiazide | 223 | 630 | 59 | $1,612 |
| Eliquis Apixaban | 205 | 288 | 35 | $162K |
| Valsartan Generic | 191 | 469 | 51 | $4,941 |
| Lorazepam Generic | 173 | 197 | 60 | $816 |
Brand drugs: 1,841 claims; generic drugs: 11,328 claims; opioid claims: 289.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert F Palguta Jr. $86.23 ($86.23 in general payments such as food, travel and fees) from 1 company. The largest payer was Medtronic, Inc. with $86.23.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 1 | $86.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.